Canagliflozin inhibits inflammasome activation in diabetic endothelial cells – Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin on human diabetic endothelial cells - Li, X; Kerindongo, R P; Preckel, B (Biomed Pharmacother, 2023)